These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point. Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705 [TBL] [Abstract][Full Text] [Related]
5. Renal transplantation in AA amyloidosis associated with Whipple's disease. Rocha S; Lobato L; Carvalho MJ; Malheiro J; Vizcaíno R; Rodrigues A; Cabrita A Amyloid; 2011 Dec; 18(4):240-4. PubMed ID: 21995309 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin light chain amyloidosis and the kidney. Gertz MA; Lacy MQ; Dispenzieri A Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079 [TBL] [Abstract][Full Text] [Related]
9. [Chronic inflammation and AA amyloidosis]. Blank N; Schönland SO Dtsch Med Wochenschr; 2013 Sep; 138(37):1835-8. PubMed ID: 24006165 [TBL] [Abstract][Full Text] [Related]
10. [Nephrotic syndrome as the initial symptom of Crohn disease]. Kullmann F; Kullmann M; Leser HG; Krämer BK; Riegger AJ; Schölmerich J Z Gastroenterol; 1996 Nov; 34(11):757-62. PubMed ID: 9045538 [TBL] [Abstract][Full Text] [Related]
11. A long-term remission of renal amyloidosis with nephrotic syndrome after autologous peripheral blood stem-cell transplantation. Ogawa K; Ikeda K; Furukawa M; Harada-Shirado K; Mashimo Y; Takahashi H; Matsumoto H; Kimura S; Shichishima-Nakamura A; Ohkawara H; Hashimoto Y; Asahi K; Noji H; Ohto H; Takeishi Y Fukushima J Med Sci; 2010 Dec; 56(2):151-6. PubMed ID: 21502717 [TBL] [Abstract][Full Text] [Related]
12. Renal-limited AL amyloidosis - a diagnostic and management dilemma. Fuah KW; Lim CTS BMC Nephrol; 2018 Nov; 19(1):307. PubMed ID: 30400895 [TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of AL amyloidosis. Sezer O; Eucker J; Jakob C; Possinger K Clin Nephrol; 2000 Jun; 53(6):417-23. PubMed ID: 10879660 [TBL] [Abstract][Full Text] [Related]
15. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293 [TBL] [Abstract][Full Text] [Related]
16. [Systemic amyloidosis revealed by an intense nephrotic syndrome]. Sanmartin N; Janvier F; Chianea D; Fagot T; Renard C; Vest P Ann Biol Clin (Paris); 2011; 69(1):121-5. PubMed ID: 21464002 [TBL] [Abstract][Full Text] [Related]
20. [Advances in diagnosis and treatment of AL amyloidosis]. Zelichowski G; Lubas A; Wańkowicz Z Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]